Corrigendum to "Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON)" [Epilepsy Behav 102 (2020) 106655]
Epilepsy Behav
.
2020 Mar;104(Pt A):106917.
doi: 10.1016/j.yebeh.2020.106917.
Epub 2020 Jan 28.
Authors
Javier Abril Jaramillo
1
,
José Carlos Estévez María
2
,
Juan Miguel Girón Úbeda
3
,
Óscar Vega López
4
,
María Elena Calzado Rivas
3
,
Hernando Pérez Díaz
5
,
Guillermina García Martín
6
,
Elena Vila Herrero
7
,
María Isabel Chamorro Muñoz
6
,
Fernando Vázquez Gutiérrez
8
,
Cristina de la Fuente Cañete
9
,
Luis Redondo Verge
10
,
Nazaret Peláez Viña
2
,
Patricia Santágueda
11
,
Juan Jesús Rodríguez Uranga
5
Affiliations
1
Centro de Neurología Avanzada, Sevilla, Spain. Electronic address: javierabriljaramillo@hotmail.com.
2
Hospital Reina Sofía, Córdoba, Spain.
3
Hospital de Jerez de la Frontera, Jeréz, Spain.
4
Hospital Cruz Roja, Córdoba, Spain.
5
Centro de Neurología Avanzada, Sevilla, Spain.
6
Hospital Vírgen de la Victoria, Málaga, Spain.
7
Hospital de Quirón Málaga, Spain.
8
Hospital de Torrecárdenas, Almería, Spain.
9
Hospital Vithas Xanit, Málaga, Spain.
10
Hospital Vírgen Macarena, Spain.
11
Biodatos S.A., Madrid, Spain.
PMID:
32005527
DOI:
10.1016/j.yebeh.2020.106917
No abstract available
Publication types
Published Erratum